Anebulo Pharmaceuticals (ANEB) Consolidated Net Income (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) recorded Consolidated Net Income of -$2.55 million in fiscal Q2 2026 (quarter ended Dec 31, 2025), compared with -$2.68 million a year earlier.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Consolidated Net Income (2020 - 2025) Analysis & Trends
On a TTM basis, Anebulo Pharmaceuticals' Consolidated Net Income came in at -$9 million as of Dec 31, 2025; for FY2025 (ended Jun 30, 2025), it was -$9.37 million.
- Across earlier fiscal years, Consolidated Net Income came in at -$8.26 million in FY2024, -$11.69 million in FY2023, -$6.82 million in FY2022 and -$3.61 million in FY2021.
- Quarterly Consolidated Net Income has ranged from -$3.8 million in fiscal Q2 2023 to -$555,832 in fiscal Q3 2021 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$2.17 million (Q1 2026), -$2.24 million (Q4 2025) and -$2.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | -2.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.55 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -2.24 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | -2.68 Mn |
| Sep 30, 2024 | -2.49 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -1.66 Mn |
| Dec 31, 2023 | -2.72 Mn |
| Sep 30, 2023 | -2.49 Mn |
| Jun 30, 2023 | -2.49 Mn |
| Mar 31, 2023 | -2.78 Mn |
| Dec 31, 2022 | -3.80 Mn |
| Sep 30, 2022 | -2.61 Mn |
| Jun 30, 2022 | -2.33 Mn |
| Mar 31, 2022 | -1.88 Mn |
| Dec 31, 2021 | -1.07 Mn |
| Sep 30, 2021 | -1.55 Mn |
| Jun 30, 2021 | -2.47 Mn |
| Mar 31, 2021 | -555,832.00 |
API Access
Anebulo Pharmaceuticals Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();